体外診断（IVD）試薬市場- 世界の産業規模、動向、機会、予測、タイプ別、技術別、用途別、エンドユーザー別、地域別、競合別、2019-2029年

体外診断（IVD）試薬の世界市場は、2023年に767億5,000万米ドルと評価され、2029年までのCAGRは5.05%で、予測期間中に目覚ましい成長を予測しています。

体外診断（IVD）試薬市場は、ヘルスケア産業における重要なセグメントであり、正確な疾病診断と患者管理に不可欠です。体外診断用試薬は、体内の様々な疾患や状態を検出するための臨床検査で使用される重要なコンポーネントであり、臨床医に効果的な治療を決定するための重要な情報を提供します。この市場は、現代ヘルスケアにおける重要性を際立たせるいくつかの要因によって、著しい成長と多様化を遂げています。IVD試薬市場の主な促進要因は、慢性疾患の世界の蔓延です。糖尿病、心血管疾患、がん、HIVや肝炎などの感染症が増加しています。IVD試薬はこれらの疾患の診断に重要な役割を果たし、早期発見、疾患モニタリング、治療評価を可能にします。慢性疾患の罹患率が増加し続ける中、IVD試薬が提供する高度な診断ツールに対する需要が高まっています。

市場の成長を促すもう一つの要因は、疾病の早期発見が重視されるようになってきたことです。タイムリーな診断は、効果的な疾病管理と患者の予後改善に不可欠です。IVD試薬は疾患の早期発見を容易にし、迅速な介入と個別化された治療計画を可能にします。早期診断は治療の成功率を高めるだけでなく、合併症や入院を防ぐことでヘルスケアの負担を軽減します。診断技術の進歩はIVD試薬市場に革命をもたらしました。分子診断、イムノアッセイ、次世代シーケンシングなどの技術革新により、診断検査の精度と感度が向上しています。IVDシステムの自動化と検査室情報管理システムとの統合は、診断検査室におけるワークフローの効率を高めています。

世界の高齢者人口の増加も市場の成長に寄与しています。高齢者は慢性疾患や感染症に罹患しやすく、加齢に関連した病態を監視・管理するための診断検査への需要が高まっています。IVD試薬は高齢者ヘルスケアにおいて重要な役割を果たしており、疾患の早期発見と管理をサポートしています。個別化医療とゲノミクスにおけるIVD試薬の用途拡大が市場拡大を後押ししています。個別化医療は、体外診断用医薬品が提供する正確な診断情報に依存し、標的治療を導き、治療結果を最適化します。体外診断用医薬品市場は、正確な疾病診断と患者ケアの必要性により、継続的な革新と成長を特徴としています。技術の進歩、疾病の増加、高齢化、個別化医療とゲノミクスにおける用途の拡大により、市場は持続的な成長と開発の態勢を整えています。

主な市場促進要因

診断技術の進歩

個別化医療とゲノム医療における用途の拡大

主な市場課題

急速な技術革新

規制遵守

コスト圧力

市場の細分化

主要市場動向

個別化医療の統合

ポイントオブケア検査の拡大

デジタル化とデータ分析

分子診断学の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の体外診断（IVD）試薬市場の見通し

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（抗体、精製タンパク質およびペプチド、オリゴヌクレオチド、その他）
  • 技術別（免疫測定、臨床化学、分子診断、微生物学、血液学、その他）
  • 用途別（臨床用途、調査用途、その他）
  • エンドユーザー別（IVDメーカー、学術機関および調査機関、病院研究室、その他）
  • 地域別
  • 企業別（2023）
• 市場マップ
  • タイプ別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 地域別

第5章 アジア太平洋地域の体外診断（IVD）試薬市場の見通し

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の体外診断（IVD）試薬市場の見通し

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の体外診断（IVD）試薬市場の見通し

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の体外診断（IVD）試薬市場の見通し

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東およびアフリカの体外診断（IVD）試薬市場の見通し

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 世界の体外診断（IVD）試薬市場： SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Thermo Fisher Scientific Inc
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc
• Agilent Technologies, Inc.
• QIAGEN N.V.
• Merck KGaA
• Beckman Coulter, Inc
• Hologic, Inc
• Abcam Ltd.
• Bio-Techne Corp

第15章 戦略的提言

第16章 調査会社について・免責事項

Global In Vitro Diagnostic (IVD) Reagents Market was valued at USD 76.75 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.05% through 2029. The In Vitro Diagnostic (IVD) Reagents Market is a critical segment within the healthcare industry, essential for accurate disease diagnosis and patient management. IVD reagents are vital components used in laboratory tests to detect various diseases and conditions in the body, providing clinicians with essential information for effective treatment decisions. The market has experienced significant growth and diversification, driven by several factors that highlight its importance in modern healthcare. A primary driver of the IVD Reagents Market is the increasing prevalence of chronic diseases globally. Conditions like diabetes, cardiovascular diseases, cancer, and infectious diseases such as HIV and hepatitis are on the rise. IVD reagents play a crucial role in diagnosing these diseases, enabling early detection, disease monitoring, and treatment assessment. As the incidence of chronic diseases continues to increase, there is a growing demand for advanced diagnostic tools provided by IVD reagents.

Another factor fueling market growth is the rising emphasis on early disease detection. Timely diagnosis is essential for effective disease management and improved patient outcomes. IVD reagents facilitate early disease detection, allowing for prompt intervention and personalized treatment plans. Early diagnosis not only enhances treatment success but also reduces healthcare burdens by preventing complications and hospitalizations. Technological advancements in diagnostics have revolutionized the IVD Reagents Market. Innovations such as molecular diagnostics, immunoassays, and next-generation sequencing have improved the precision and sensitivity of diagnostic tests. Automation and integration of IVD systems with laboratory information management systems have enhanced workflow efficiency in diagnostic laboratories.

The growing geriatric population worldwide has also contributed to market growth. Elderly individuals are more susceptible to chronic and infectious diseases, driving the demand for diagnostic tests to monitor and manage age-related conditions. IVD reagents play a vital role in geriatric healthcare, supporting early disease detection and management. Expanding applications of IVD reagents in personalized medicine and genomics have bolstered market expansion. Personalized medicine relies on accurate diagnostic information provided by IVD reagents, guiding targeted therapies and optimizing treatment outcomes. The IVD Reagents Market is characterized by continuous innovation and growth, driven by the need for accurate disease diagnosis and patient care. With advancements in technology, increasing disease prevalence, an aging population, and expanding applications in personalized medicine and genomics, the market is poised for sustained growth and development.

Key Market Drivers

Technological advancements in diagnostics

Technological advancements in diagnostics are driving the In Vitro Diagnostic (IVD) Reagents Market by enhancing the accuracy, speed, and breadth of diagnostic tests. Innovations such as molecular diagnostics, immunoassays, and automation have significantly improved the sensitivity and specificity of tests, enabling early and precise disease detection. Integration with digital platforms, data analytics, and artificial intelligence further optimize diagnostic processes, improving efficiency and outcomes. These advancements enable healthcare professionals to make informed decisions, enhancing patient care. Additionally, continuous research and development in diagnostic technologies foster the creation of new and improved IVD reagents, expanding the market's scope and ensuring its prominence in modern healthcare.

Expanding applications in personalized medicine and genomic

Expanding applications in personalized medicine and genomics are driving the In Vitro Diagnostic (IVD) Reagents Market by revolutionizing disease diagnosis and treatment. IVD reagents play a crucial role in genomic testing, biomarker analysis, and companion diagnostics, providing essential information for tailored therapies. As the healthcare industry shifts towards personalized medicine, these reagents enable precise identification of genetic markers and disease profiles, guiding targeted treatments and improving patient outcomes. The growing demand for personalized healthcare solutions propels the market, encouraging continuous research and development in IVD reagents. Their indispensable role in optimizing treatment strategies ensures a robust and expanding market presence in the realm of advanced medical diagnostics.

Key Market Challenges

Rapid Technological Changes

Rapid technological changes present a significant challenge for the In Vitro Diagnostic (IVD) Reagents Market. Continuous advancements in diagnostic technologies lead to frequent updates and introductions of new testing methods and reagents. Keeping up with these rapid changes requires substantial investments in research, development, and training for healthcare professionals. Additionally, integrating new technologies into existing healthcare systems poses logistical challenges, demanding seamless interoperability. Market players must balance innovation with practical implementation, ensuring that new reagents align with regulatory standards and meet the specific needs of diverse healthcare settings. Adapting swiftly to these technological shifts while maintaining quality and reliability remains a complex challenge in the dynamic IVD reagents landscape.

Regulatory Compliance

Regulatory compliance poses a significant challenge for the In Vitro Diagnostic (IVD) Reagents Market. Strict regulations govern the development, manufacturing, and distribution of diagnostic reagents to ensure their safety, efficacy, and accuracy. Navigating complex and evolving regulatory frameworks, varying from region to region, demands meticulous adherence to standards and extensive documentation. Meeting these requirements often entails substantial time and financial investments, delaying product launches and market entry. Additionally, keeping abreast of regulatory updates and policy changes is crucial. Companies must maintain rigorous quality control, conduct comprehensive testing, and engage in transparent reporting to satisfy regulatory authorities, making compliance a formidable challenge in the competitive and heavily regulated IVD reagents industry.

Cost Pressure

Cost pressure poses a significant challenge for the In Vitro Diagnostic (IVD) Reagents Market. Healthcare systems worldwide face budget constraints, compelling providers to seek cost-effective solutions without compromising quality. In this environment, IVD reagent manufacturers are under immense pressure to reduce production costs while maintaining high standards of accuracy and reliability. Price sensitivity among consumers and healthcare facilities further intensifies this challenge. Balancing affordability with innovation and quality necessitates efficient supply chain management, optimized manufacturing processes, and strategic pricing strategies. Companies must innovate not only in product development but also in cost-efficient production methods to remain competitive, addressing the industry's relentless cost pressures.

Market Fragmentation

Market fragmentation in the In Vitro Diagnostic (IVD) Reagents Market refers to the industry's division into numerous small and specialized segments. This fragmentation arises from the diverse range of diagnostic tests, each requiring specific reagents. With the constant evolution of medical technologies, diagnostic methods, and disease understanding, new, specialized tests continually emerge, catering to niche markets. As a result, the IVD reagents industry becomes fragmented, with various manufacturers focusing on specific tests or technologies. While this specialization allows for innovation, it also presents challenges in standardization, distribution, and market penetration, requiring companies to navigate a complex landscape to reach diverse customer needs effectively.

Key Market Trends

Personalized Medicine Integration

Personalized Medicine Integration stands out as a significant trend in the In Vitro Diagnostic (IVD) Reagents Market. With advancements in genomics and molecular diagnostics, IVD reagents are crucial in identifying specific genetic markers, enabling tailored treatments for individual patients. This trend emphasizes the need for highly precise and specialized diagnostic tools. By integrating personalized medicine approaches, healthcare providers can offer targeted therapies, optimizing treatment outcomes and minimizing adverse effects. IVD reagents play a pivotal role in this paradigm shift, providing the essential data necessary to customize treatment plans. As the trend toward personalized medicine gains momentum, the demand for innovative and accurate IVD reagents continues to rise, reshaping the landscape of diagnostic healthcare.

Point-of-Care Testing Expansion

Point-of-Care Testing (POCT) Expansion is a transformative trend in the In Vitro Diagnostic (IVD) Reagents Market, revolutionizing healthcare delivery. The growing emphasis on rapid and convenient diagnostic solutions has spurred the development of portable, easy-to-use testing devices. These advancements enable healthcare professionals to conduct diagnostic tests closer to patients, reducing turnaround times and enabling quicker interventions. IVD reagents tailored for POCT devices are essential, ensuring accurate and reliable results in diverse settings, from clinics to remote areas. The trend toward decentralized testing enhances accessibility, improves patient outcomes, and accelerates disease management, driving the demand for specialized IVD reagents designed for point-of-care applications and reshaping the IVD market landscape.

Digitalization and Data Analytics

Digitalization and Data Analytics have become pivotal trends in the In Vitro Diagnostic (IVD) Reagents Market, transforming the landscape of medical diagnostics. Advanced software and data analytics tools are being integrated with IVD reagents, enabling real-time monitoring, interpretation of test results, and predictive analysis. This integration enhances the efficiency of diagnostics, allowing for rapid and accurate interpretation of complex data sets. Healthcare providers can make informed decisions swiftly, leading to personalized patient care and improved outcomes. Additionally, digital platforms facilitate remote monitoring and telemedicine, expanding access to diagnostic services. As the industry embraces digitalization, the demand for IVD reagents compatible with these technologies continues to rise, driving market growth and innovation.

Molecular Diagnostics Advancements

Molecular Diagnostics Advancements are reshaping the In Vitro Diagnostic (IVD) Reagents Market, heralding a new era of precision and personalized medicine. The continuous evolution of molecular techniques, including polymerase chain reaction (PCR), nucleic acid sequencing, and gene expression profiling, enables the detection of specific DNA, RNA, and protein markers associated with diseases. IVD reagents play a central role in these advanced diagnostic methods, facilitating the identification of genetic mutations, infectious agents, and biomarkers linked to various conditions. These innovations enhance diagnostic accuracy, enabling early disease detection and targeted therapies. The demand for highly specialized IVD reagents, designed for molecular diagnostics, drives market growth, reflecting the industry's focus on cutting-edge, molecular-based healthcare solutions.

Segmental Insights

Technology Insights

Based on the Treatment, Immunoassays have established dominance in the In Vitro Diagnostic (IVD) Reagents Market due to their versatility, sensitivity, and wide applicability. These assays utilize antibodies to detect specific proteins, hormones, or antigens, enabling the diagnosis of a diverse range of diseases, including infectious, autoimmune, and hormonal disorders. Their accuracy, rapid results, and ability to measure multiple analytes simultaneously make them invaluable in clinical laboratories. Immunoassays also play a crucial role in cancer markers detection, cardiac biomarker testing, and allergy diagnostics. As a result, the demand for specialized IVD reagents for immunoassay platforms remains consistently high, making them the preferred choice for clinicians and diagnosticians worldwide.

Type Insights

Antibodies have become dominant in the In Vitro Diagnostic (IVD) Reagents Market due to their pivotal role in various diagnostic techniques. These specific proteins are crucial components of immunoassays, binding to specific antigens and enabling the accurate detection of diseases, pathogens, and biomarkers. Monoclonal antibodies, in particular, are engineered for high specificity and reproducibility, ensuring reliable diagnostic results. Their versatility allows for diverse applications, including infectious disease testing, cancer diagnostics, and autoimmune disorder screening. As the demand for precise and rapid diagnostics rises, the need for specialized IVD reagents featuring antibodies remains paramount, solidifying their dominance and indispensability in the IVD market.

Regional Insights

North America stands as the dominant region in the In Vitro Diagnostic (IVD) Reagents Market due to several factors. The region boasts advanced healthcare infrastructure, extensive research and development activities, and high healthcare spending, fostering the development of innovative diagnostic solutions. Additionally, a well-established pharmaceutical industry, supportive regulatory frameworks, and a large base of key market players contribute to the region's prominence. Moreover, a high prevalence of chronic diseases, rising awareness about early disease detection, and a favorable reimbursement scenario drive the demand for IVD reagents. These factors, combined with a sophisticated healthcare ecosystem and ongoing technological advancements, solidify North America's leading position in the global IVD reagents market.

Key Market Players

Thermo Fisher Scientific Inc

Becton, Dickinson and Company

Bio-Rad Laboratories, Inc

Agilent Technologies, Inc.

QIAGEN N.V.

Merck KGaA

Beckman Coulter, Inc

Hologic, Inc

Abcam Ltd

Bio-Techne Corp

Report Scope:

In this report, the Global In Vitro Diagnostic (IVD) Reagents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

In Vitro Diagnostic (IVD) Reagents Market, By Type:

Antibodies Purified Proteins and Peptides Oligonucleotides Others

In Vitro Diagnostic (IVD) Reagents Market, By Technology:

Immunoassay Clinical Chemistry Molecular Diagnostics Microbiology Hematology Others

In Vitro Diagnostic (IVD) Reagents Market, By Use:

Clinical Use Research Use Others

In Vitro Diagnostic (IVD) Reagents Market, By End user:

IVD Manufacturers Academic Institutes & Research Laboratories Hospital Laboratories Others

In Vitro Diagnostic (IVD) Reagents Market, By Region:

North America
• United States
• Canada
• Mexico
Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
South America
• Brazil
• Argentina
• Colombia
Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the In Vitro Diagnostic (IVD) Reagents Market.

Available Customizations:

Global In Vitro Diagnostic (IVD) Reagents market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global In Vitro Diagnostic (IVD) Reagents Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Type (Antibodies, Purified Proteins and Peptides, Oligonucleotides, Others)
  • 4.2.2. By Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Others)
  • 4.2.3. By Use (Clinical Use, Research Use, Others)
  • 4.2.4. By End User (IVD Manufacturers, Academic Institutes & Research Laboratories, Hospital Laboratories, Others)
  • 4.2.5. By Region
  • 4.2.6. By Company (2023)
• 4.3. Market Map
  • 4.3.1. By Type
  • 4.3.2. By Technology
  • 4.3.3. By Use
  • 4.3.4. By End user
  • 4.3.5. By Region

5. Asia Pacific In Vitro Diagnostic (IVD) Reagents Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type
  • 5.2.2. By Technology
  • 5.2.3. By Use
  • 5.2.4. By End user
  • 5.2.5. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Type
      • 5.3.1.2.2. By Technology
      • 5.3.1.2.3. By Use
      • 5.3.1.2.4. By End user
  • 5.3.2. India In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Type
      • 5.3.2.2.2. By Technology
      • 5.3.2.2.3. By Use
      • 5.3.2.2.4. By End user
  • 5.3.3. Australia In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Type
      • 5.3.3.2.2. By Technology
      • 5.3.3.2.3. By Use
      • 5.3.3.2.4. By End user
  • 5.3.4. Japan In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Type
      • 5.3.4.2.2. By Technology
      • 5.3.4.2.3. By Use
      • 5.3.4.2.4. By End user
  • 5.3.5. South Korea In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Type
      • 5.3.5.2.2. By Technology
      • 5.3.5.2.3. By Use
      • 5.3.5.2.4. By End user

6. Europe In Vitro Diagnostic (IVD) Reagents Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Technology
  • 6.2.3. By Use
  • 6.2.4. By End user
  • 6.2.5. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Use
      • 6.3.1.2.4. By End user
  • 6.3.2. Germany In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Use
      • 6.3.2.2.4. By End user
  • 6.3.3. Spain In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Use
      • 6.3.3.2.4. By End user
  • 6.3.4. Italy In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By Technology
      • 6.3.4.2.3. By Use
      • 6.3.4.2.4. By End user
  • 6.3.5. United Kingdom In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By Technology
      • 6.3.5.2.3. By Use
      • 6.3.5.2.4. By End user

7. North America In Vitro Diagnostic (IVD) Reagents Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Technology
  • 7.2.3. By Use
  • 7.2.4. By End user
  • 7.2.5. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Use
      • 7.3.1.2.4. By End user
  • 7.3.2. Mexico In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Use
      • 7.3.2.2.4. By End user
  • 7.3.3. Canada In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Use
      • 7.3.3.2.4. By End user

8. South America In Vitro Diagnostic (IVD) Reagents Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Technology
  • 8.2.3. By Use
  • 8.2.4. By End user
  • 8.2.5. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Use
      • 8.3.1.2.4. By End user
  • 8.3.2. Argentina In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Use
      • 8.3.2.2.4. By End user
  • 8.3.3. Colombia In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Use
      • 8.3.3.2.4. By End user

9. Middle East and Africa In Vitro Diagnostic (IVD) Reagents Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Technology
  • 9.2.3. By Use
  • 9.2.4. By End user
  • 9.2.5. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Use
      • 9.3.1.2.4. By End user
  • 9.3.2. Saudi Arabia In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Use
      • 9.3.2.2.4. By End user
  • 9.3.3. UAE In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Use
      • 9.3.3.2.4. By End user

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global In Vitro Diagnostic (IVD) Reagents Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific Inc
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Product & Services
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. SWOT Analysis
• 14.2. Becton, Dickinson and Company
• 14.3. Bio-Rad Laboratories, Inc
• 14.4. Agilent Technologies, Inc.
• 14.5. QIAGEN N.V.
• 14.6. Merck KGaA
• 14.7. Beckman Coulter, Inc
• 14.8. Hologic, Inc
• 14.9. Abcam Ltd.
• 14.10.Bio-Techne Corp

15. Strategic Recommendations

16. About Us & Disclaimer